Ardent Health [ARDT] vs Astrana Health [ASTH] Detailed Stock Comparison

Ardent Health Partners Inc.

NYSE
Loading...

Astrana Health Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Ardent Health Partners Inc. wins in 16 metrics, Astrana Health Inc. wins in 3 metrics, with 0 ties. Ardent Health Partners Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ardent Health Partners Inc. Astrana Health Inc. Better
P/E Ratio (TTM) 10.26 73.30 Ardent Health Partners Inc.
Price-to-Book Ratio 1.09 2.12 Ardent Health Partners Inc.
Debt-to-Equity Ratio 137.57 193.10 Ardent Health Partners Inc.
PEG Ratio 8.44 -0.41 Ardent Health Partners Inc.
EV/EBITDA 7.09 14.57 Ardent Health Partners Inc.
Profit Margin (TTM) 2.15% 0.71% Ardent Health Partners Inc.
Operating Margin (TTM) 6.53% 1.85% Ardent Health Partners Inc.
EBITDA Margin (TTM) 6.53% 1.85% Ardent Health Partners Inc.
Return on Equity 14.35% 4.49% Ardent Health Partners Inc.
Return on Assets (TTM) 3.97% 3.43% Ardent Health Partners Inc.
Free Cash Flow (TTM) $258.61M $104.49M Ardent Health Partners Inc.
1-Year Return -36.26% 51.75% Astrana Health Inc.
Price-to-Sales Ratio (TTM) 0.22 0.59 Ardent Health Partners Inc.
Enterprise Value $3.41B $2.10B Ardent Health Partners Inc.
EV/Revenue Ratio 0.54 0.66 Ardent Health Partners Inc.
Gross Profit Margin (TTM) 42.13% 10.00% Ardent Health Partners Inc.
Revenue per Share (TTM) $45 $65 Astrana Health Inc.
Earnings per Share (Diluted) $0.96 $0.46 Ardent Health Partners Inc.
Beta (Stock Volatility) N/A 0.77 N/A
Short % of Float 8.61% 8.35% Astrana Health Inc.

Ardent Health Partners Inc. vs Astrana Health Inc. Stock Performance Analysis

Loading Price Chart...

ARDT
ASTH

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ardent Health Partners Inc.-15.53%-16.70%-21.54%-16.79%-12.32%-9.38%
Astrana Health Inc.-0.65%-4.80%4.83%49.61%59.30%45.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ardent Health Partners Inc.-36.26%-46.65%-46.65%-46.65%-46.65%-46.65%
Astrana Health Inc.51.75%11.50%1.87%585.25%637.65%637.65%

Performance & Financial Health Analysis: Ardent Health Partners Inc. vs Astrana Health Inc.

MetricARDTASTH
Market Information
Market Cap i$1.39B$1.88B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i333,798497,178
90 Day Avg. Volume i343,166435,283
Last Close$7.83$36.67
52 Week Range$7.71 - $15.48$18.08 - $39.93
% from 52W High-49.42%-8.16%
All-Time High$20.72 (Oct 14, 2024)$133.23 (Nov 15, 2021)
% from All-Time High-62.21%-72.48%
Growth Metrics
Quarterly Revenue Growth0.00%0.43%
Quarterly Earnings Growth-0.61%0.43%
Financial Health
Profit Margin (TTM) i0.02%0.01%
Operating Margin (TTM) i0.07%0.02%
Return on Equity (TTM) i0.14%0.04%
Debt to Equity (MRQ) i137.57193.10
Cash & Liquidity
Book Value per Share (MRQ)$9.02$15.94
Cash per Share (MRQ)$4.99$8.68
Operating Cash Flow (TTM) i$470.51M$114.60M
Levered Free Cash Flow (TTM) i$155.97M$227.95M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Ardent Health Partners Inc. vs Astrana Health Inc.

MetricARDT (Apr 24, 2026)ASTH (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i10.2673.30
Forward P/E i8.4410.50
PEG Ratio i8.44-0.41
Price to Sales (TTM) i0.220.59
Price to Book (MRQ) i1.092.12
Market Capitalization
Market Capitalization i$1.39B$1.88B
Enterprise Value i$3.41B$2.10B
Enterprise Value Metrics
Enterprise to Revenue i0.540.66
Enterprise to EBITDA i7.0914.57
Risk & Other Metrics
Beta iN/A0.77
Book Value per Share (MRQ) i$9.02$15.94

Financial Statements Comparison: Ardent Health Partners Inc. vs Astrana Health Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricARDT (2025)ASTH (2025)
Revenue/Sales i6.32B3.18B
Cost of Goods Sold i3.74B2.84B
COGS % of Revenue i59.1%89.3%
Gross Profit i2.58B341.53M
Gross Margin i40.9%10.7%
Research & Development iN/AN/A
Operating Income (EBIT) i325.58M78.53M
Operating Margin i5.1%2.5%
EBITDA i504.61M135.35M
EBITDA Margin i8.0%4.3%
Pre-Tax Income i286.36M39.61M
Pre-Tax Income % of Revenue i4.5%1.2%
Income Tax i56.22M15.53M
Income Tax % of Revenue i0.9%0.5%
Net Income (Profit) i230.14M24.08M
Profit Margin i3.6%0.8%

Balance Sheet & Liquidity Metrics

MetricARDT (2025)ASTH (2025)
Cash & Equivalents i709.60M429.47M
Total Current Assets i2.06B863.31M
Total Current Assets % of Revenue i32.6%27.1%
Total Current Liabilities i1.05B615.27M
Total Current Liabilities % of Revenue i16.5%19.3%
Long-Term Debt i2.24B1.02B
Long-Term Debt % of Revenue i35.4%32.1%
Total Shareholders Equity i1.68B558.33M
Retained Earnings i501.61M308.38M
Retained Earnings % of Revenue i7.9%9.7%
Property, Plant & Equipment i2.51B35.74M

Cash Flow Statement Comparison

MetricARDT (2025)ASTH (2025)
Operating Cash Flow i592.45M109.88M
Operating Cash Flow % of Revenue i9.4%3.5%
Capital Expenditures i-211.90M-10.11M
Free Cash Flow i258.61M104.49M
FCF Margin i4.1%3.3%
Debt Repayment i-7.99M-495.29M
Common Stock Repurchase iN/A-15.43M

Short Interest & Institutional Ownership Analysis

MetricARDTASTH
Shares Short i2.84M2.68M
Short Ratio i7.126.86
Short % of Float i8.61%8.35%
Shares Outstanding i142.86M48.89M
Float Shares i23.89M44.36M
% Held by Insiders i23.42%20.32%
% Held by Institutions i74.79%52.52%
% Held by Public i1.79%27.16%

Dividend Analysis & Yield Comparison: Ardent Health Partners Inc. vs Astrana Health Inc.

MetricARDTASTH
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A